EXCLUSIVE: Invitae CEO On Making Genetics Cost-Effective And Accessible
San Francisco-headquartered Invitae Corp (NYSE: NVTA) defines itself as medical genetics company seeking to bring comprehensive genetic information into mainstream medicine, with the goal of improving outcomes and lowering health care expenses.
